CRMD - CorMedix Inc Stock Price, Fair Value and News

$10.75-0.32 (-2.89%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

CRMD Price Action

Last 7 days

-5.3%

Last 30 days

-4.0%

Last 90 days

110.8%

Trailing 12 Months

197.0%

CRMD RSI Chart

CRMD Valuation

Market Cap

652.3M

Price/Earnings (Trailing)

-14.13

Price/Sales (Trailing)

12.1K

EV/EBITDA

-14.55

Price/Free Cashflow

-11.62

CRMD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

CRMD Fundamentals

CRMD Revenue

Revenue (TTM)

65.4K

Rev. Growth (Yr)

5.0K%

Rev. Growth (Qtr)

1.3K%

CRMD Earnings

Earnings (TTM)

-46.1M

Earnings Growth (Yr)

71.5%

Earnings Growth (Qtr)

80.38%

CRMD Profitability

Operating Margin

96.63%

EBT Margin

-65028.05%

Return on Equity

-78.6%

Return on Assets

-59.48%

Free Cashflow Yield

-8.61%

CRMD Investor Care

Shares Dilution (1Y)

10.70%

Diluted EPS (TTM)

-0.8

CRMD Alerts

1 major insider sales recently.

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	0	0	0	0
2023	0	0	0	0
2022	27.2K	39.9K	52.7K	65.4K
2021	253.4K	245.2K	190.3K	14.4K
2020	193.6K	174.8K	208.3K	239.2K
2019	570.3K	598.0K	285.0K	283.3K
2018	313.0K	184.4K	495.8K	429.8K
2017	222.2K	341.9K	358.5K	329.3K
2016	220.3K	116.8K	125.3K	224.1K
2015	208.3K	288.6K	272.1K	210.1K
2014	0	0	0	189.3K
2013	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

About CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath and Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

CEO	Mr. Joseph Todisco MBA
WEBSITE	cormedix.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	40

CorMedix Inc Frequently Asked Questions

What is the ticker symbol for CorMedix Inc? What does CRMD stand for in stocks?

CRMD is the stock ticker symbol of CorMedix Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of CorMedix Inc (CRMD)?

As of Wed Nov 20 2024, market cap of CorMedix Inc is 652.28 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CRMD stock?

You can check CRMD's fair value in chart for subscribers.

Is CorMedix Inc a good stock to buy?

The fair value guage provides a quick view whether CRMD is over valued or under valued. Whether CorMedix Inc is cheap or expensive depends on the assumptions which impact CorMedix Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CRMD.

What is CorMedix Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Nov 20 2024, CRMD's PE ratio (Price to Earnings) is -14.13 and Price to Sales (PS) ratio is 12.1 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CRMD PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on CorMedix Inc's stock?

In the past 10 years, CorMedix Inc has provided 0.037 (multiply by 100 for percentage) rate of return.